diaDexus (OTCBB: DDXS) is a San Francisco-based company focused on the development and commercialization of proprietary cardiovascular diagnostic products that address unmet needs in cardiovascular disease. The company’s PLAC Test ELISA Kit is the only FDA-approved blood test that aids in predicting risk for both coronary heart disease and ischemic stroke associated with atherosclerosis. The company’s CE-marked PLAC Test for Lp-PLA2 Activity is an indicator of atherosclerotic cardiovascular disease. For more information, visit the company’s Web site at www.diaDexus.com

B. Riley & Co. provides a full array of corporate finance, research, sales, trading, and otcqx dad services to corporate, institutional, and high net worth clients.  Headquartered in Los Angeles, with offices in San Francisco, New York, and Newport Beach, the firm is recognized for its distinguished equity research, merger and acquisitions advisory services, initial and secondary public offerings, and institutional private placements. For more information on B. Riley & Co., visit www.brileyco.com

Let us hear your thoughts below: